{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:28:47Z","timestamp":1792877327148,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key R&D Program of China","award":["2017 YFC 13097004"],"award-info":[{"award-number":["2017 YFC 13097004"]}]},{"DOI":"10.13039\/100017378","name":"Shanghai Key Discipline for Respiratory Diseases","doi-asserted-by":"crossref","award":["2017ZZ02014"],"award-info":[{"award-number":["2017ZZ02014"]}],"id":[{"id":"10.13039\/100017378","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The European Organization for Research and Treatment of Cancer\/Mycoses Study Group (EORTC\/MSG) criteria are widely used in the diagnosis of invasive pulmonary aspergillosis (IPA), but they only apply to immunocompromised patients. We here aimed to identify clinical characteristics helpful to the diagnosis of IPA in non-immunocompromised patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This is a multicenter retrospective study. Data were collected from adult patients with IPA admitted to 15\n                      <jats:bold>tertiary hospitals in China<\/jats:bold>\n                      from 2010 to 2016.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We included 254 patients in the study, of whom 66 (26.0%) were immunocompromised, and 188 (74.0%) were not. Airway-invasion-associated computed tomography (CT) signs including patchy exudation along the airway (67.6% vs. 45.5%,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.001) and thickened airway wall (42.0% vs. 16.7%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) were more common in non-immunocompromised patients than in immunocompromised ones, and angio-invasive CT signs were more common in immunocompromised patients (55.3% vs.72.7%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.013). Typical angio-invasive CT signs were delayed in non-immunocompromised IPA patients, whereas airway-invasive signs appear earlier. Host immunocompromised condition was associated with ICU admission and\/or intubation (OR 1.095; 95% CI 1.461\u20136.122;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003). Poor prognosis (35.5% vs. 21.1%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.005) was more common in immunocompromised patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Airway-invasion-associated CT presentations at early stages of the disease are characteristic of IPA in non-immunocompromised hosts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-020-01424-x","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T09:03:59Z","timestamp":1594112639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Airway-invasion-associated pulmonary computed tomography presentations characteristic of invasive pulmonary Aspergillosis in non-immunocompromised adults: a National Multicenter Retrospective Survey in China"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhibo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxiang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieming","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0904-1429","authenticated-orcid":false,"given":"Bin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"key":"1424_CR1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of cancer\/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases mycoses study group (EORTC\/MSG) consensus group. Clin Infect Dis. 2008;46:1813\u201321.","journal-title":"Clin Infect Dis"},{"key":"1424_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1179\/acb.2004.037","volume":"59","author":"K Vandewoude","year":"2004","unstructured":"Vandewoude K, Blot S, Benoit D, Depuydt P, Vogelaers D, Colardyn F. Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality. Acta Clin Belg. 2004;59:251\u20137.","journal-title":"Acta Clin Belg"},{"key":"1424_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1183\/09059180.00001011","volume":"20","author":"M Kousha","year":"2011","unstructured":"Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev. 2011;20:156\u201374.","journal-title":"Eur Respir Rev"},{"issue":"Suppl 1","key":"1424_CR4","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.3109\/13693786.2010.505204","volume":"49","author":"JW Baddley","year":"2011","unstructured":"Baddley JW. Clinical risk factors for invasive aspergillosis. Med Mycol. 2011;49(Suppl 1):S7\u2013S12.","journal-title":"Med Mycol"},{"key":"1424_CR5","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","volume":"6","author":"A Schauwvlieghe","year":"2018","unstructured":"Schauwvlieghe A, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, Lagrou K, Verweij PE, Van de Veerdonk FL, Gommers D, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6:782\u201392.","journal-title":"Lancet Respir Med"},{"key":"1424_CR6","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1183\/09031936.00062206","volume":"30","author":"P Bulpa","year":"2007","unstructured":"Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007;30:782\u2013800.","journal-title":"Eur Respir J"},{"key":"1424_CR7","first-page":"296","volume":"14","author":"F Ghanaat","year":"2017","unstructured":"Ghanaat F, Tayek JA. Weight loss and diabetes are new risk factors for the development of invasive aspergillosis infection in non-immunocompromized humans. Clin Pract (Lond). 2017;14:296\u2013301.","journal-title":"Clin Pract (Lond)"},{"key":"1424_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1086\/509917","volume":"44","author":"RE Greene","year":"2007","unstructured":"Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, Wingard JR, Herbrecht R, Ribaud P, Patterson TF, et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis. 2007;44:373\u20139.","journal-title":"Clin Infect Dis"},{"key":"1424_CR9","doi-asserted-by":"crossref","unstructured":"Horger M, Hebart H, Einsele H, Lengerke C, Claussen CD, Vonthein R, Pfannenberg C. Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome? Eur J Radiol. 2005;55:437\u201344.","DOI":"10.1016\/j.ejrad.2005.01.001"},{"key":"1424_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/crj.12551","volume":"12","author":"L Huang","year":"2018","unstructured":"Huang L, He H, Ding Y, Jin J, Zhan Q. Values of radiological examinations for the diagnosis and prognosis of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary diseases. Clin Respir J. 2018;12:499\u2013509.","journal-title":"Clin Respir J"},{"key":"1424_CR11","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.3324\/haematol.2013.094359","volume":"98","author":"M Nucci","year":"2013","unstructured":"Nucci M, Nouer SA, Cappone D, Anaissie E. Early diagnosis of invasive pulmonary aspergillosis in hematologic patients: an opportunity to improve the outcome. Haematologica. 2013;98:1657\u201360.","journal-title":"Haematologica"},{"key":"1424_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S0966-842X(01)02104-7","volume":"9","author":"JP Latge","year":"2001","unstructured":"Latge JP. The pathobiology of Aspergillus fumigatus. Trends Microbiol. 2001;9:382\u20139.","journal-title":"Trends Microbiol"},{"key":"1424_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000455125","volume":"9","author":"JM Garth","year":"2017","unstructured":"Garth JM, Steele C. Innate lung defense during invasive Aspergillosis: new mechanisms. J Innate Immun. 2017;9:271\u201380.","journal-title":"J Innate Immun"},{"key":"1424_CR14","doi-asserted-by":"publisher","first-page":"S211","DOI":"10.1093\/mmy\/myy057","volume":"57","author":"C Cunha","year":"2019","unstructured":"Cunha C, Carvalho A. Genetic defects in fungal recognition and susceptibility to invasive pulmonary aspergillosis. Med Mycol. 2019;57:S211\u20138.","journal-title":"Med Mycol"},{"key":"1424_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","volume":"170","author":"W Meersseman","year":"2004","unstructured":"Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med. 2004;170:621\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"1424_CR16","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1182\/blood-2011-04-351601","volume":"119","author":"A Bergeron","year":"2012","unstructured":"Bergeron A, Porcher R, Sulahian A, de Bazelaire C, Chagnon K, Raffoux E, Vekhoff A, Cornet M, Isnard F, Brethon B, et al. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood. 2012;119:1831\u20137 quiz 1956.","journal-title":"Blood"},{"key":"1424_CR17","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1086\/657065","volume":"51","author":"M Nucci","year":"2010","unstructured":"Nucci M, Nouer SA, Grazziutti M, Kumar NS, Barlogie B, Anaissie E. Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies. Clin Infect Dis. 2010;51:1273\u201380.","journal-title":"Clin Infect Dis"},{"key":"1424_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1469-0691.2011.03503.x","volume":"18","author":"H Xu","year":"2012","unstructured":"Xu H, Li L, Huang WJ, Wang LX, Li WF, Yuan WF. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China. Clin Microbiol Infect. 2012;18:403\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"1424_CR19","doi-asserted-by":"publisher","unstructured":"Nucci M. Is Early Invasive Pulmonary Aspergillosis Coming of Age? Clin Infect Dis. 2020;70(2):347. https:\/\/doi.org\/10.1093\/cid\/ciz381.","DOI":"10.1093\/cid\/ciz381"},{"key":"1424_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/myc.12480","volume":"59","author":"F Maccioni","year":"2016","unstructured":"Maccioni F, Vetere S, De Felice C, Al Ansari N, Micozzi A, Gentile G, Foa R, Girmenia C. Pulmonary fungal infections in patients with acute myeloid leukaemia: is it the time to revise the radiological diagnostic criteria? Mycoses. 2016;59:357\u201364.","journal-title":"Mycoses"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01424-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-020-01424-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01424-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T19:22:33Z","timestamp":1625599353000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-020-01424-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1424"],"URL":"https:\/\/doi.org\/10.1186\/s12931-020-01424-x","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,7]]},"assertion":[{"value":"3 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the institutional review board (No. 2017\u2013205)<b>.<\/b>","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}